Pancreatic cancer! How long can you live, to be exact?

Less than half a year... It has been reported that the average survival time of pancreatic cancer is less than 6 months, and its 5-year survival rate is less than 5%, but there are many cases of long-term survival after menstruation. Therefore, it is difficult to have a definitive answer to the question of how long you can live with advanced pancreatic cancer. Pancreatic cancer** is a systemic process, and its efficacy is influenced by a variety of factors.

In general, how long you can live with advanced pancreatic cancer depends on whether the method is appropriate and the patient's physical fitness. In addition, patients and their families should know more about the prevention and treatment of pancreatic cancer, which will also help to prolong the survival of patients with advanced pancreatic cancer.

Jaundice is the first manifestation in 10% = 20% of pancreatic cancer patients, and 56% to 78% of patients have jaundice throughout the course of the disease. The tumor is located in the head of the pancreas, and 625-90% of patients have jaundice. The vast majority of jaundice in pancreatic cancer is obstructive jaundice.

It is generally believed that pancreatic tail cancer is usually absent from jaundice, and jaundice is rarely the first symptom, but jaundice can occur in about 5% of advanced stages.

If the advanced stage of pancreatic cancer is not progressive, the patient's complications will make the patient very painful, it is difficult for the patient to take care of himself in the painful life, the family burden is serious, and the patient's life is lost in the pain. Experts point out that how to prolong the life of pancreatic cancer patients is closely related to improving physical fitness and controlling the occurrence of complications.

Niu Xiaopei, an oncologist at Deshengmen, said: Generally speaking, the opportunity for surgery is basically lost in the advanced stage of pancreatic cancer, and radiotherapy and chemotherapy and symptomatic treatment are commonly used in Western medicine. Evidence-based medical studies have shown that patients with advanced pancreatic cancer are excessive**, and the harm is obvious.

If there are patients with advanced pancreatic cancer, pancreatic cancer has metastasized and spread in multiple places, and it is impossible to undergo ** surgery, and if there are no life-threatening complications, surgery is harmful and useless;

Some patients have repeated chemotherapy, resulting in leukopenia and weakness, at this time, rechemotherapy will only increase the pain and accelerate death; In some patients, the sequelae of radiotherapy caused by over-radiotherapy are often more painful and difficult to treat than pancreatic cancer itself. The toxicity and dependence of Western medicine in the symptomatic ** will also cause irreparable damage to the body.

In addition, conventional various biological immunization**, because it does not break the immunosuppression around the tumor, the imported immune cells not only cannot enter the tumor, but most of them are destroyed and inactivated by the immune factors secreted by the tumor, and its efficacy is very small and susceptible to infection. Experts remind that due to the poor constitution of patients with advanced pancreatic cancer, try to avoid the traumatic way so as not to accelerate the death of the patient.

Pancreatic cancer is a common digestive system tumor with a very high degree of malignancy, with three characteristics of difficult to find, easy to metastasize, difficult to **, statistics show that the current 5-year survival rate of pancreatic cancer patients is about 5%, but if it can be taken actively and effectively, including advanced patients who have the opportunity to do surgery and no chance to do surgery, for patients who have the opportunity to do sexual surgery, but also do a standardized postoperative comprehensive **, such as **surgery combined with chemotherapy, radiotherapy and other comprehensive**, the 5-year survival rate can be increased to about 20%, It can be seen that active and effective** can significantly improve the survival rate of patients.